搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
centerforbiosimilars
14 小时
BioRationality: A Critical Analysis of Pfizer Views on Sustainability of Biosimilars
The top gastroenterology biosimilar news from 2024 highlight fluctuations in the adalimumab biosimilar market throughout the ...
centerforbiosimilars
14 小时
Top 5 Most-Read Legal Articles of 2024
The top legal stories in biosimilars from 2024 emphasize the ongoing struggle between ensuring timely patient access and ...
centerforbiosimilars
2 天
The Top 5 Most-Read Gastroenterology Articles of 2024
The top gastroenterology biosimilar news from 2024 highlight fluctuations in the adalimumab biosimilar market throughout the ...
centerforbiosimilars
1 天
Empowering Vulnerable Populations: The Path to Equitable Biologic Therapy Access
Elie Bahou, PharmD, senior vice president and system chief pharmacy officer at Providence, discusses strategies to improve equitable access to biologic therapies, including tiered formularies, ...
centerforbiosimilars
4 天
China's Biosimilar Market: Trastuzumab Uptake and Future Trends
China's trastuzumab biosimilar market is growing but lags behind European countries, with biosimilars gradually increasing ...
centerforbiosimilars
1 天
Ashling Wahner
Strengthening the Supply Chain: Key Insights From FDA Commissioner Dr Robert Califf ...
centerforbiosimilars
6 天
Study Shows Biosimilarity of Bevacizumab Biosimilar in CRC
A recent study showed similar safety and efficacy of a bevacizumab biosimilar compared with the reference product (Avastin) ...
centerforbiosimilars
5 天
13 Strategies to Avoid the Nocebo Effect During Biosimilar Switching
A systematic review identified 13 strategies, including patient and provider education, empathetic communication, and shared ...
centerforbiosimilars
10 天
Trastuzumab’s Evergreening Impact on Biosimilars, Health Care Costs
The impact of pharmaceutical companies' evergreening strategies on the adoption of trastuzumab biosimilars in the Netherlands ...
centerforbiosimilars
7 天
Health Canada Approves First Omalizumab Biosimilar
Health Canada has approved Omlyclo, the first omalizumab biosimilar in Canada, for the treatment of chronic idiopathic ...
centerforbiosimilars
10 天
The Top 5 Biosimilar Articles for the Week of December 9
Number 5: Alvotech and Advanz Pharma have submitted a European marketing application for their golimumab biosimilar to treat ...
centerforbiosimilars
13 天
BioRationality: Withdrawal of Proposed Terminal Disclaimer Rule Spells Major Setback for ...
The United States Patent and Trademark Office (USPTO)’s withdrawal of its proposed terminal disclaimer rule is seen as a ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈